In addition, the A6E mutation codon could be incorporated into the ASNS gene of patients with acute lymphoblastic leukemia to minimize the risk of developing a resistance to the asparaginase treatment, as A6E mutation can block the attempt at ASNS overexpression by the cancer cells. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.